| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |